Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation

NCT05244408 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05244408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05244408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Recruiting
Start date
March 17, 2023
Completion date
December 30, 2030
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute spinal cord injury, acute spinal paralysis, spinal cord injuries, trauma, spinal cord